CORRELATION BETWEEN INDIRECT IMMUNOFLUORESCENCE ANTI-NUCLEAR ANTIBODIES PATTERNS AND SPECIFIC NUCLEAR ANTIBODIES IN SOME COMMON SYSTEMIC AUTOIMMUNE DISEASES
Main Article Content
Abstract
Background: Approximately 3-5% of the population is affected including 100 types of autoimmune diseases. Antinuclear antibody (ANA) is an important biomarker for autoimmune diseases, detected by indirect immunofluorescence (IIF) method. This method has been applied wildly in several hospitals; however, there is no synchronous and complete assessment of autoantibodies. Method: This cross-sectional study was conducted on 110 medical records of individuals diagnosed with autoimmune diseases at Vinmec International Hospital from Januanry 2020 to June 2022. The IIF were performed to determine the presence of ANA. Result: The presence of ANA varies across the following diseases: undifferentiated connective tissue disease (UCTD) 82.3%, systemic sclerosis (SSc) 77.8%, systemic lupus erythematosus (SLE) 71.4%, polymyositis/dermatomyositis (PM/DM) 53.3%. The most common deposition patterns were speckled pattern and homogenous pattern. In homogenous pattern, the dsDNA, histone and nucleosomes antibodies were found frequently. Scl-70 and Ro-52 antibodies were detected in all five diseases which were studied. Conclusion: The presence of ANA detected by IIF were significantly high in UCTD, SSc, SLE, and PM/DM. The deposition patterns and the specific antibodies were different and diseases-specific.
Article Details
Keywords
ANA, lupus erythematosus, dermatomyositis/polymyositis, Sjogren Syndrome, Undifferentiated connective tissue disease
References
2. Tzioufas AG, Tatouli IP, Moutsopoulos HM. Autoantibodies in Sjögren’s syndrome: clinical presentation and regulatory mechanisms. Presse Med. 2012 Sep;41(9 Pt 2):e451-460.
3. Ungprasert P, Leeaphorn N, Hosiriluck N, Chaiwatcharayut W, Ammannagari N, Raddatz DA. Clinical Features of Inflammatory Myopathies and Their Association with Malignancy: A Systematic Review in Asian Population. ISRN Rheumatol. 2013 Feb 25; 2013:509354.
4. Wei Q, Jiang Y, Xie J, Lv Q, Xie Y, Tu L, et al. Analysis of antinuclear antibody titers and patterns by using HEp‐2 and primate liver tissue substrate indirect immunofluorescence assay in patients with systemic autoimmune rheumatic diseases. J Clin Lab Anal. 2020 Oct 13;34(12):e23546.
5. Banhuk FW, Pahim BC, Jorge AS, Menolli RA. Relationships among Antibodies against Extractable Nuclear Antigens, Antinuclear Antibodies, and Autoimmune Diseases in a Brazilian Public Hospital. Autoimmune Dis. 2018 Sep 30;2018:9856910.
6. Lee SA, Kahng J, Kim Y, Park Y, Han K, Kwok S, et al. Comparative Study of Immunofluorescent Antinuclear Antibody Test and Line Immunoassay Detecting 15 Specific Autoantibodies in Patients With Systemic Rheumatic Disease. J Clin Lab Anal. 2012 Jul 18;26(4):307–14.
7. Guidelines for immunologic laboratory testing in the rheumatic diseases: Anti‐DNA antibody tests. [cited 2022 Apr 26]; Available from: https://onlinelibrary. wiley.com/doi/10.1002/art.10558
8. Qu C, Zhang J, Zhang X, Du J, Su B, Li H. Value of combined detection of anti-nuclear antibody, anti-double-stranded DNA antibody and C3, C4 complements in the clinical diagnosis of systemic lupus erythematosus. Exp Ther Med. 2019 Feb;17(2):1390–4.
9. Patel R, Shahane A. The epidemiology of Sjögren’s syndrome. Clin Epidemiol. 2014 Jul 30;6:247–55.